Veerhealth Care Limited - 511523 - Closure of Trading Window
Intimation of Closure of Trading Window26-06-2024
26-06-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed Investors Presentation on the Audited Financial Results for the quarter and year ended 31st March, 2024.26-06-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
In continuation of the letter dated June 08, 2024 related to the Investor Conference Call to discuss the Financial Results for the Quarter ended March 31, 2024 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Transcripts of the Company''s Investor Call.19-06-2024
Veerhealth Care Limited - 511523 - 'Ayuveer' Products Now Available On Nykaa For Purchase
We are delighted to announce that our brand Ayuveer''s products have successfully completed the onboarding process on Nykaa''s mobile application and website.14-06-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to our letter dated June 08, 2024 related to the Investor Conference Call and pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and Guidance note issued by the Stock Exchange dated July 29, 2022, we hereby inform you that the audio call recording of the Company''s Investor Call to discuss the Financial Results for the Quarter ended March 31, 2024 is available on the website of the Company www.veerhealthcare.net. The link to access the said audio recording is: https://veerhealthcare.net/wp-content/uploads/2024/06/Earning-Concall-Audio-of-Veerhealth-Care-Limited-Q4-FY24.mp3 Mr. Bhavin Shah, Managing Director and Mr. Akash Shah, Chief Financial Officer were the Management attendees. It is further confirmed that no unpublished price sensitive information was shared/discussed in the meeting / call.12-06-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Management team of the Company shall be participating in Q4 FY23-24 earnings call scheduled on Wednesday, June 12, 2024 at 2.00 pm (IST) hosted by Kirin Advisors. Please find attached details of the invitation.08-06-2024
Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 Of SEBI LODR - Appointment Of Internal And Secretarial Auditor
Please find attached herewith the details under Regulation 30 of SEBI LODR for appointment of Internal and Secretarial Auditor.30-05-2024
Veerhealth Care Limited - 511523 - Results-Financial Results For March 31, 2024
Please find attached Audited Financial Results for the quarter and year ended 31st March, 2024.30-05-2024
Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. May 30, 2024 as under: 1. The Board has approved and taken on record Audited Financial Results for the quarter and year ended March 31, 2024. 2. To conserve resources of the Company, the Board has not recommended any dividend on equity shares of the Company for the financial year ended March 31, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 5.00 p.m.30-05-2024
Veerhealth Care Limited - 511523 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024.27-05-2024